{"id":"W2243168506","doi":"10.1200/jco.2009.27.15_suppl.5576","title":"A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Regimen; Phases of clinical research; Endometrial cancer; Oncology; Gastroenterology; Clinical endpoint; Urology; Cancer; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002248885,0.001141687,0.001623381,0.0003546295,0.0003870656,0.0005596835,0.000656948,0.001237137,0.004081697],"category_scores_gemma":[0.0009858082,0.0004229201,0.0008490066,0.0002433068,0.000594894,0.0004960431,0.0003331025,0.001908137,0.0006715923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000722649,"about_ca_system_score_gemma":0.001443419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008259104,"about_ca_topic_score_gemma":0.001968967,"domain_scores_codex":[0.9995228,0.0002746071,0.00001915753,0.00006411468,0.00004681819,0.00007247367],"domain_scores_gemma":[0.9993736,0.0001108805,0.0001083484,0.00004340668,0.00003955911,0.0003242803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7000197,0.046763,0.01142522,0.001611048,0.001675565,0.0005527778,0.0004262376,0.003483875,0.04385543,0.0005751395,0.01071999,0.1788921],"study_design_scores_gemma":[0.7830122,0.1984665,0.01203398,0.00003719869,0.0002800786,0.0003162074,0.00003299338,0.001177207,0.001702495,0.0001728647,0.002745401,0.00002287613],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869387,0.003836165,0.0005919875,0.0008190271,0.0001337807,0.004550079,0.00103894,0.00008022865,0.002011113],"genre_scores_gemma":[0.9812949,0.002567668,0.0031274,0.0016905,0.0002535693,0.004565767,0.00242827,0.00002734109,0.00404454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004081697,"threshold_uncertainty_score":0.01365465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2843529791827545,"score_gpt":0.5407086601337543,"score_spread":0.2563556809509998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}